Carrie Condon

Carrie Condon has extensive experience in clinical operations, working in various roles at different biopharmaceutical companies. In 2005, they joined Acceleron Pharma as a Sr Manager, Clinical Operations, where they served until 2014. From 2014 to 2016, they worked as a Clinical Project Manager at Infinity Pharmaceuticals. In 2017, they joined BeiGene as an Associate Director, Clinical Operations, and held the position until 2018. From 2018 to 2020, they served as an Associate Director Clinical Operations at Magenta Therapeutics. Currently, they are working as the Director Clinical Operations at Stoke Therapeutics, a position they started in October 2020.

Carrie Condon attended Penn State University from 1995 to 1999, where they earned a Bachelor of Science degree in Microbiology, General. Carrie then pursued further education at Boston University from 2003 to 2005, obtaining a Master's degree in Public Health (MPH), specializing in Epidemiology and Biostatistics.